Maria Eugénia Marques da Costa

Recent advances in understanding osteosarcoma and emerging therapies

A. Marchais, O. Fromigué, P. Berlanga, 2020, Faculty reviews.

Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice

B. Geoerger, E. Daudigeos-Dubus, O. Bawa, 2018, Cancer medicine.

Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

P. Gestraud, D. Surdez, O. Delattre, 2022, bioRxiv.

Immune infiltrate and tumor microenvironment transcriptional programs stratify pediatric osteosarcoma into prognostic groups at diagnosis.

D. Drubay, B. Job, B. Geoerger, 2022, Cancer research.

In-Vitro and In-Vivo Establishment and Characterization of Bioluminescent Orthotopic Chemotherapy-Resistant Human Osteosarcoma Models in NSG Mice

B. Job, B. Geoerger, A. Marchais, 2019, Cancers.

CellsFromSpace: A versatile tool for spatial transcriptomic data analysis with reference-free deconvolution and guided cell type/activity annotation

A. Marchais, Gaël Moquin-Beaudry, Maria Eugénia Marques da Costa, 2023, bioRxiv.

Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice

B. Geoerger, E. Daudigeos-Dubus, O. Bawa, 2018, Cancer medicine.

A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors

L. Zitvogel, D. Surdez, S. Cairo, 2023, Communications biology.

From biology to personalized medicine: recent knowledge in Osteosarcoma.

A. Marchais, Maria Eugénia Marques da Costa, Robin Droit, 2024, European journal of medical genetics.